Related Experiment Video

Updated: Jul 8, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

High frequency of unrecognized mental disorders in HCV-infected patients

Susana Carolina Batista-Neves1, Lucas C Quarantini, Amanda Galvão de Almeida

  • 1University Hospital, Faculdade de Medicina, Universidade Federal da Bahia, Bahia, Brazil.

General Hospital Psychiatry
|January 1, 2008
PubMed

Insights

Hepatitis C virus (HCV) patients frequently experience psychiatric disorders, with nearly half diagnosed. A significant majority of these mental health conditions in HCV patients remain unrecognized and untreated.

Area of Science:

  • Hepatology
  • Psychiatry
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection is associated with various extrahepatic manifestations, including psychiatric disorders.
  • Understanding the prevalence of psychiatric comorbidities in HCV patients is crucial for comprehensive patient care.

Purpose of the Study:

  • To determine the frequency of psychiatric disorders among hepatitis C virus (HCV)-infected patients.
  • To assess the rate of undiagnosed psychiatric morbidity in this population.

Main Methods:

  • A cross-sectional study was conducted with 90 HCV-infected outpatients at a university hospital in northeastern Brazil.
  • The Mini International Neuropsychiatric Interview was used to assess psychiatric diagnoses.

Main Results:

  • Nearly half (49%) of the 90 HCV patients had at least one psychiatric diagnosis.
  • Among patients with current psychiatric morbidity (26), a substantial majority (84.6%) were undiagnosed.

Conclusions:

  • HCV-infected patients exhibit a high frequency of psychiatric comorbidity.
  • A significant proportion of psychiatric conditions in HCV patients go unrecognized, highlighting a need for improved screening and management.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...